429 related articles for article (PubMed ID: 10774662)
1. Cutaneous delayed-type hypersensitivity responsiveness in lepromatous and borderline lepromatous leprosy patients as determined by MULTITEST CMI.
Walsh DS; Villahermosa LG; Balagon MV; Abalos RM; Fajardo TT; Tan EV; Cellona RV; Walsh GP
Southeast Asian J Trop Med Public Health; 1999 Sep; 30(3):518-26. PubMed ID: 10774662
[TBL] [Abstract][Full Text] [Related]
2. Delayed-type hypersensitivity reactions followed by erythema nodosum leprosum.
Rea TH; Sieling PA
Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):316-27. PubMed ID: 9934358
[TBL] [Abstract][Full Text] [Related]
3. Cell-mediated immunity in healthy and uremic adults assessed by in vivo and in vitro techniques. Validation of delayed hypersensitivity skin testing.
López M; Jerez J; González M; Arias M
Allergol Immunopathol (Madr); 1989; 17(1):21-8. PubMed ID: 2750637
[TBL] [Abstract][Full Text] [Related]
4. Immunological profile of treated lepromatous leprosy patients.
Joshi B; Girdhar BK; Mohanty KK; Beuria MK; Girdhar A; Sengupta U
Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):195-203. PubMed ID: 11875763
[TBL] [Abstract][Full Text] [Related]
5. Immunologic defects in leprosy patients. I. Evidence of immune aberration of suppressor-T lymphocytes in lepromatous leprosy.
Makonkawkeyoon S; Kasinrerk W; Dettrairat S; Vithayasai V
Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):302-10. PubMed ID: 2142947
[TBL] [Abstract][Full Text] [Related]
6. Type 1 reactions in leprosy--heterogeneity in T-cell functions related to the background leprosy type.
Laal S; Mishra RS; Nath I
Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):481-93. PubMed ID: 2958570
[TBL] [Abstract][Full Text] [Related]
7. Cell mediated immunity in school children assessed by Multitest CMI skin testing II. Epidemiologic factors affecting immune responsiveness.
Lesourd BM; Corriel RN; McBryde JL; Kniker WT
Ann Allergy; 1985 May; 54(5):446-52. PubMed ID: 3994073
[TBL] [Abstract][Full Text] [Related]
8. Multitest CMI for standardized measurement of delayed cutaneous hypersensitivity and cell-mediated immunity. Normal values and proposed scoring system for healthy adults in the U.S.A.
Kniker WT; Anderson CT; McBryde JL; Roumiantzeff M; Lesourd B
Ann Allergy; 1984 Feb; 52(2):75-82. PubMed ID: 6696298
[TBL] [Abstract][Full Text] [Related]
9. New lesions after MDT in PB and MB leprosy: a report of 28 cases.
Kar HK; Sharma P
Indian J Lepr; 2008; 80(3):247-55. PubMed ID: 19432355
[TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
Narang T; Kaur I; Kumar B; Radotra BD; Dogra S
Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
[TBL] [Abstract][Full Text] [Related]
11. Lepromatous leprosy treated with combined chemotherapy and immunotherapy (injection BCG): three case reports.
Lakshmi C; Srinivas CR
Int J Dermatol; 2014 Jan; 53(1):61-5. PubMed ID: 23675902
[TBL] [Abstract][Full Text] [Related]
12. Leprosy reactions. New knowledge.
Naafs B
Trop Geogr Med; 1994; 46(2):80-4. PubMed ID: 8079395
[No Abstract] [Full Text] [Related]
13. Light and electron microscopic study of peripheral nerve damage in patients with lepromatous leprosy (LL) and borderline lepromatous leprosy (BL).
Kajihara H; Paturusi IA; Saleh RM; Rasyad C; Ikuta Y
Hiroshima J Med Sci; 2000 Mar; 49(1):83-92. PubMed ID: 10824461
[TBL] [Abstract][Full Text] [Related]
14. Ocular complications in incident relapsed borderline lepromatous and lepromatous leprosy patients in south India.
Daniel E; Koshy S; Joseph GA; Rao PS
Indian J Ophthalmol; 2003 Jun; 51(2):155-9. PubMed ID: 12831146
[TBL] [Abstract][Full Text] [Related]
15. [Clinical usefulness of Multitest in the evaluation of cellular immunity].
Feijoó RM; Ardiles A; Lemp P; King A; Villamán JJ; Parra A; Silva M
Rev Med Chil; 1996 Mar; 124(3):327-36. PubMed ID: 9008945
[TBL] [Abstract][Full Text] [Related]
16. Immunological studies in leprosy. III-Cutaneous response to antigens in spectrum of leprosy.
Singh PK; Ratna ; Jain PK; Mital VP
Indian J Lepr; 1984; 56(2):257-63. PubMed ID: 6548495
[TBL] [Abstract][Full Text] [Related]
17. Prognostic evaluation of cell mediated immunity in leprosy and correlation with clinicopathological status of leprosy patients.
Aziz M; Malik A; Abbas SM; Vasenwala S; Kalam A
Indian J Pathol Microbiol; 1996 Jan; 39(1):5-12. PubMed ID: 8755125
[TBL] [Abstract][Full Text] [Related]
18. Delayed cutaneous hypersensitivity: multitest CMI reliability assessment in groups of volunteers.
Murgueytio PU; Evans RG
Ann Allergy; 1988 Dec; 61(6):463-5. PubMed ID: 3202336
[TBL] [Abstract][Full Text] [Related]
19. Erythrocyte superoxide dismutase, catalase activities and hydrogen peroxide induced lipid peroxidation in leprosy.
Prasad CV; Kodliwadmath MV; Kodliwadmath GB
Lepr Rev; 2007 Dec; 78(4):391-7. PubMed ID: 18309714
[TBL] [Abstract][Full Text] [Related]
20. Study of serum zinc level in leprosy.
Saxena N; Sharma RP; Singh VS
Indian J Lepr; 1988 Oct; 60(4):556-61. PubMed ID: 3253334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
